Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 5
1968 4
1969 6
1970 2
1971 1
1972 1
1973 1
1974 2
1975 2
1976 3
1977 1
1978 2
1979 1
1980 2
1982 2
1985 3
1986 2
1988 3
1990 2
1991 3
1992 6
1993 5
1994 3
1995 4
1996 8
1997 2
1998 4
1999 3
2000 7
2001 1
2002 4
2003 3
2004 7
2005 9
2006 3
2007 6
2008 6
2009 7
2010 2
2011 5
2012 9
2013 10
2014 17
2015 22
2016 7
2017 18
2018 13
2019 11
2020 11
2021 7
2022 11
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Results by year

Filters applied: . Clear all
Page 1
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
Domínguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gröschel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR Jr, Lange C; TBnet and RESIST-TB networks. Domínguez J, et al. Among authors: cox v. Lancet Infect Dis. 2023 Apr;23(4):e122-e137. doi: 10.1016/S1473-3099(22)00875-1. Epub 2023 Feb 28. Lancet Infect Dis. 2023. PMID: 36868253 Review.
Tumor markers: myths and facts unfolded.
Faria SC, Sagebiel T, Patnana M, Cox V, Viswanathan C, Lall C, Qayyum A, Bhosale PR. Faria SC, et al. Among authors: cox v. Abdom Radiol (NY). 2019 Apr;44(4):1575-1600. doi: 10.1007/s00261-018-1845-0. Abdom Radiol (NY). 2019. PMID: 30498924 Review.
Genetics of pancreatic cancer and implications for therapy.
Bhosale P, Cox V, Faria S, Javadi S, Viswanathan C, Koay E, Tamm E. Bhosale P, et al. Among authors: cox v. Abdom Radiol (NY). 2018 Feb;43(2):404-414. doi: 10.1007/s00261-017-1394-y. Abdom Radiol (NY). 2018. PMID: 29177925 Review.
IgE Antibodies against Cancer: Efficacy and Safety.
Chauhan J, McCraw AJ, Nakamura M, Osborn G, Sow HS, Cox VF, Stavraka C, Josephs DH, Spicer JF, Karagiannis SN, Bax HJ. Chauhan J, et al. Among authors: cox vf. Antibodies (Basel). 2020 Oct 16;9(4):55. doi: 10.3390/antib9040055. Antibodies (Basel). 2020. PMID: 33081206 Free PMC article. Review.
Lynch Syndrome: Genomics Update and Imaging Review.
Cox VL, Saeed Bamashmos AA, Foo WC, Gupta S, Yedururi S, Garg N, Kang HC. Cox VL, et al. Radiographics. 2018 Mar-Apr;38(2):483-499. doi: 10.1148/rg.2018170075. Radiographics. 2018. PMID: 29528821 Review.
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients.
NeuroLINCS Consortium; Li J, Lim RG, Kaye JA, Dardov V, Coyne AN, Wu J, Milani P, Cheng A, Thompson TG, Ornelas L, Frank A, Adam M, Banuelos MG, Casale M, Cox V, Escalante-Chong R, Daigle JG, Gomez E, Hayes L, Holewenski R, Lei S, Lenail A, Lima L, Mandefro B, Matlock A, Panther L, Patel-Murray NL, Pham J, Ramamoorthy D, Sachs K, Shelley B, Stocksdale J, Trost H, Wilhelm M, Venkatraman V, Wassie BT, Wyman S, Yang S; NYGC ALS Consortium; Van Eyk JE, Lloyd TE, Finkbeiner S, Fraenkel E, Rothstein JD, Sareen D, Svendsen CN, Thompson LM. NeuroLINCS Consortium, et al. Among authors: cox v. iScience. 2021 Oct 12;24(11):103221. doi: 10.1016/j.isci.2021.103221. eCollection 2021 Nov 19. iScience. 2021. PMID: 34746695 Free PMC article.
Early mortality during rifampicin-resistant TB treatment.
Mohr-Holland E, Daniels J, Reuter A, Rodriguez CA, Mitnick C, Kock Y, Cox V, Furin J, Cox H. Mohr-Holland E, et al. Among authors: cox v. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):150-157. doi: 10.5588/ijtld.21.0494. Int J Tuberc Lung Dis. 2022. PMID: 35086627 Free PMC article.
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?
Reuter A, Tisile P, von Delft D, Cox H, Cox V, Ditiu L, Garcia-Prats A, Koenig S, Lessem E, Nathavitharana R, Seddon JA, Stillo J, von Delft A, Furin J. Reuter A, et al. Among authors: cox v. Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1114-1126. doi: 10.5588/ijtld.17.0468. Int J Tuberc Lung Dis. 2017. PMID: 29037291 Review.
271 results